Humira, Enbrel, Remicade, Avastin, Nivolumab, Tecfidera, Revlimid, Rituxan, Soliris, Imbruvica, Herceptin, Kadcycla, Perjeta, Botox, Simponi, Gamaggard iquid, Xgeva/Prolia, Neulasta, Stelara, Spiriva

The Top 20 Selling Orphan Drugs of 2020

In Market Access by CecileLeave a Comment

This list of the top 20 selling orphan drugs of 2020 highlights the growing importance of orphan drugs in the pharmaceutical industry. With estimates placing the worth of the orphan industry at $127 billion by 2018, here’s what you should know about the top selling orphan drugs in 2020.

Read about the top selling orphan drugs launched in 2013 here

Humira, Enbrel, Remicade, Avastin, Nivolumab, Tecfidera, Revlimid, Rituxan, Soliris, Imbruvica, Herceptin, Kadcycla, Perjeta, Botox, Simponi, Gamaggard iquid, Xgeva/Prolia, Neulasta, Stelara, Spiriva

Whilst all of the drug included have recieved orphan designation, the total sales figure for each drug may well include sales for non-orphan indications.

 

Humira, Enbrel, Remicade, Avastin, Nivolumab, Tecfidera, Revlimid, Rituxan, Soliris, Imbruvica, Herceptin, Kadcycla, Perjeta, Botox, Simponi, Gamaggard iquid, Xgeva/Prolia, Neulasta, Stelara, Spiriva

Leave a Comment